BackMerrimack Pharmaceuticals Overview

Merrimack Pharmaceuticals Operating Income

Operating Income for MACK.

Quarterly Operating Income

$-669000.00
↑ 49.66% YoY

As of Mar 31, 2024

Annual Operating Income (TTM)

$-2259000.00
↑ 10.52% YoY

Trailing 12 months ending Mar 31, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin